PIVA, Roberto

PIVA, Roberto  

BIOTECNOLOGIE MOLECOLARI E SCIENZE PER LA SALUTE  

Mostra records
Risultati 1 - 20 di 104 (tempo di esecuzione: 0.029 secondi).
Titolo Data di pubblicazione Autore(i) File
15-Deoxy-delta 12,14-prostaglandin J2 induces apoptosis in human malignant B cells: an effect associated with inhibition of NF-kappa B activity and down-regulation of antiapoptotic proteins 2005 PIVA R; GIANFERRETTI P; CIUCCI A; TAULLI R; BELARDO G; SANTORO MG
A cell cycle alteration precedes apoptosis of granule cell precursors in the weaver mouse cerebellum. 1999 MIGHELI A ;PIVA R ;CASOLINO S ;ATZORI C ;DLOUHY SR ;GHETTI B
A novel patient-derived tumorgraft model with TRAF1-ALK anaplastic large-cell lymphoma translocation 2015 Abate, F.; Todaro, M.; Van Der Krogt, J.-A.; Boi, M.; Landra, I.; Machiorlatti, R.; Tabbò, F.; Messana, K.; Abele, C.; Barreca, A.; Novero, D.; Gaudiano, M.; Aliberti, S.; Di Giacomo, F.; Tousseyn, T.; Lasorsa, E.; Crescenzo, R.; Bessone, L.; Ficarra, E.; Acquaviva, A.; Rinaldi, A.; Ponzoni, M.; Longo, D.L.; Aime, S.; Cheng, M.; Ruggeri, B.; Piccaluga, P.P.; Pileri, S.; Tiacci, E.; Falini, B.; Pera-Gresely, B.; Cerchietti, L.; Iqbal, J.; Chan, W.C.; Shultz, L.D.; Kwee, I.; Piva, R.; Wlodarska, I.; Rabadan, R.; Bertoni, F.; Inghirami, G.
Ablation of oncogenic ALK is a viable therapeutic approach fAblation of oncogenic ALK is a viable therapeutic approach for anaplastic large-cell lymphomas 2006 PIVA R; CHIARLE R; MANAZZA AD; TAULLI R; SIMMONS W; AMBROGIO C; D'ESCAMARD V; PELLEGRINO E; PONZETTO C; PALESTRO G; INGHIRAMI G
Activated p38MAPK is a novel component of the intracellular inclusions found in human amyotrophic lateral sclerosis and mutant SOD1 transgenic mice 2004 BENDOTTI C; ATZORI C; PIVA R; TORTAROLO M; STRONG MJ; DEBIASI S; MIGHELI A
Activation of the JNK/p38 pathway occurs in diseases characterized by tau protein pathology and is related to tau phosphorylation but not to apoptosis. 2001 ATZORI C ;GHETTI B ;PIVA R ;SRINIVASAN AN ;ZOLO P ;DELISLE MB ;MIRRA SS ;MIGHELI A
ALK expression favorably impacts the prognosis of NRAS-mutated metastatic melanomas 2018 Osella-Abate, Simona; Mereu, Elisabetta; Pellegrino, Elisa; Bergaggio, Elisa; Ribero, Simone; Bertero, Luca; Lisa, Francesco; Fierro, Maria Teresa; Papotti, Mauro Giulio; Piva, Roberto*
ALK Signaling and Target Therapy in Anaplastic Large Cell Lymphoma 2012 Tabbó F; Barreca A; Piva R; Inghirami G; The European T-Cell Lymphoma Study Group (;Riccardo Bruna; Daniele Corino; Diego Cortese; Ramona Crescenzo; Giuditta Cuccuru; Filomena di Giacomo; Alessandro Fioravanti; Marco Ladetto; Indira Landra; Katia Messana; Rodolfo Machiorlatti; Barbara Martinoglio; Enzo Medico; Marta Mossino; Elisa Pellegrino; Maria Todaro; Paola Campisi; Luigi Chiusa; Annalisa Chiappella; Domenico Novero; Umberto Vitolo; Francesco Abate; Andrea Acquaviva; Elisa Ficarra; Roberto Freilone; Marco Chilosi; Alberto Zamó; Fabio Facchetti; Silvia Lonardi; Anna De Chiara; Franco Fulciniti; Claudio Doglioni; Maurilio Ponzoni; Luca Agnelli; Antonino Neri; Katia Todoerti; Claudio Agostinelli; Pier Paolo Piccaluga; Stefano Pileri; Brunangelo Falini; Enrico Tiacci; Peter Van Loo; Thomas Tousseyn; Christiane De Wolf-Peeters; Eva Geissinger; Hans Konrad Muller-Hermelink; Andreas Rosenwald; Miguel Angel Piris; Maria E. Rodriguez; Francesco Bertoni; Michela Boi; Ivo Kwee;)
ALK-dependent control of hypoxia-inducible factors mediates tumor growth and metastasis 2014 Martinengo, Cinzia; Poggio, Teresa; Menotti, Matteo; Scalzo, Maria Stella; Mastini, Cristina; Ambrogio, Chiara; Pellegrino, Elisa; Riera, Ludovica; Piva, Roberto; Ribatti, Domenico; Pastorino, Fabio; Perri, Patrizia; Ponzoni, Mirco; Wang, Qi; Voena, Claudia; Chiarle, Roberto
Anaplastic large cell lymphoma: one or more entities among T-cell lymphoma? 2009 Fornari A; Piva R; Chiarle R; Novero D; Inghirami G
Anaplastic large-cell lymphoma 2011 Inghirami G; Pileri SA; Chiarle R; Cuccuru G; Martinoglio B; Medico E; Pellegrino E; Piva R; Ruberto ML; Fornari A; Novero D; Chilosi M; Zamó A; Facchetti F; Lonardi S; De Chiara A; Fulciniti F; Doglioni C; Ponzoni M; Agnelli L; Neri A; Todoerti K; Agostinelli C; Piccaluga PP; Falini B; Tiacci E; Van Loo P; Tousseyn T; De Wolf-Peeters C; Geissinger E; Muller-Hermelink HK; Rosenwald A; Piris MA; Rodriguez ME.
Anaplastic lymphoma kinase (ALK) activates Stat3 and protects hematopoietic cells from cell death 2002 ZAMO A; R. CHIARLE; PIVA R; HOWES J; FAN Y; CHILOSI M; LEVY DE; INGHIRAMI G.
Anaplastic lymphoma kinase in human cancer 2011 Barreca A; Lasorsa E; Riera L; Machiorlatti R; Piva R; Ponzoni M; Kwee I; Bertoni F; Piccaluga PP; Pileri SA; Inghirami G; European T-Cell Lymphoma Study Group;(Barreca A; Chiarle R; Cuccuru G; Inghirami G; Martinoglio B; Medico E; Pellegrino E; Piva R; Ruberto ML; Voena C; Fornari A; Novero D; Chilosi M; Zamò A; Facchetti F; Lonardi S; De Chiara A; Fulciniti F; Doglioni C; Ponzoni M; Agnelli L; Neri A; Todoerti K; Piccaluga PP; Pileri S; Falini B; Tiacci E; Van Loo P; Tousseyn T; De Wolf-Peeters C; Geissinger E; Konrad Muller-Hermelink H; Rosenwald A; Piris MA; Rodriguez ME)
The AP-1-BATF and -BATF3 module is essential for growth, survival and TH17/ILC3 skewing of anaplastic large cell lymphoma 2018 Schleussner, Nikolai; Merkel, Olaf; Costanza, Mariantonia; Liang, Huan-Chang; Hummel, Franziska; Romagnani, Chiara; Durek, Pawel; Anagnostopoulos, Ioannis; Hummel, Michael; Jöhrens, Korinna; Niedobitek, Antonia; Griffin, Patrick R.; Piva, Roberto; Sczakiel, Henrike L.; Woessmann, Wilhelm; Damm-Welk, Christine; Hinze, Christian; Stoiber, Dagmar; Gillissen, Bernd; Turner, Suzanne D.; Kaergel, Eva; von Hoff, Linda; Grau, Michael; Lenz, Georg; Dörken, Bernd; Scheidereit, Claus; Kenner, Lukas; Janz, Martin; Mathas, Stephan
bcl-2 protein expression in aged brain and neurodegenerative diseases. 1994 MIGHELI A; CAVALLA P; PIVA R; GIORDANA MT; SCHIFFER D
BRAF-mediated NAMPT overexpression induces a melanoma cell dedifferentiation program leading to metabolic reprogramming and intrinsic resistant to BRAF inhibitors 2019 Valentina Audrito, Antonella Managò, Federica Gaudino, Ilaria Manfredonia, Vincenzo Gianluca Messana, Nicoletta Vitale, Lorenzo Brandimarte, Enrico Moiso, Roberto Piva, Nadia Raffaelli, Mario Mandalà, Silvia Deaglio
c-Jun, JNK/SAPK kinases and transcription factor NF-kappa B are selectively activated in astrocytes, but not motor neurons, in amyotrophic lateral sclerosis. 1997 MIGHELI A ;PIVA R ;ATZORI C ;TROOST D ;SCHIFFER D
CD30 expression in anaplastic large cell lymphomas is dependent on ALK tyrosine kinase activity via Stat3 phosphorylation and JunB upregulation 2005 Boccalatte F; Piva R; Manazza A; Palestro G; Chiarle R; Inghirami G
CDKN2/p16 inactivation and p16 immunohistochemistry in astrocytic gliomas. 1998 PIVA R ;CAVALLA P ;BORTOLOTTO S ;CORDERA S ;GROSSO R ;RICHIARDI P ;DUTTO A ;SCHIFFER D
Cell-cycle inhibitor p27/Kip-1 expression in non-astrocytic and non-oligodendrocytic human nervous system tumors. 1999 SCHIFFER D ;BORTOLOTTO S ;BOSONE I ;CANCELLI I ;CAVALLA P ;SCHIFFER P ;PIVA R